122 related articles for article (PubMed ID: 23237806)
1. Involvement of endoplasmic reticulum stress in tauopathy.
Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M
Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806
[TBL] [Abstract][Full Text] [Related]
2. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
[TBL] [Abstract][Full Text] [Related]
3. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
4. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
Kim E; Sakata K; Liao FF
PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
[TBL] [Abstract][Full Text] [Related]
7. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
[TBL] [Abstract][Full Text] [Related]
8. Hrd1 facilitates tau degradation and promotes neuron survival.
Shen YX; Sun AM; Fang S; Feng LJ; Li Q; Hou HL; Liu C; Wang HP; Shen JL; Luo J; Zhou JN
Curr Mol Med; 2012 Feb; 12(2):138-52. PubMed ID: 22280354
[TBL] [Abstract][Full Text] [Related]
9. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimer's disease pathogenesis.
Ho YS; Yang X; Lau JC; Hung CH; Wuwongse S; Zhang Q; Wang J; Baum L; So KF; Chang RC
J Alzheimers Dis; 2012; 28(4):839-54. PubMed ID: 22101233
[TBL] [Abstract][Full Text] [Related]
11. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
12. Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis.
Meier S; Bell M; Lyons DN; Rodriguez-Rivera J; Ingram A; Fontaine SN; Mechas E; Chen J; Wolozin B; LeVine H; Zhu H; Abisambra JF
J Neurosci; 2016 Jan; 36(3):1001-7. PubMed ID: 26791227
[TBL] [Abstract][Full Text] [Related]
13. Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer's Disease.
Zarini-Gakiye E; Vaezi G; Parivar K; Sanadgol N
CNS Neurol Disord Drug Targets; 2021; 20(5):451-464. PubMed ID: 33573583
[TBL] [Abstract][Full Text] [Related]
14. SPOP loss of function protects against tauopathy.
Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
[TBL] [Abstract][Full Text] [Related]
15. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: possible involvement of HRD1, a novel molecule related to endoplasmic reticulum stress, in Alzheimer's disease.
Kaneko M; Okuma Y; Nomura Y
J Pharmacol Sci; 2012; 118(3):325-30. PubMed ID: 22382662
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
Meier S; Bell M; Lyons DN; Ingram A; Chen J; Gensel JC; Zhu H; Nelson PT; Abisambra JF
J Alzheimers Dis; 2015; 48(3):687-702. PubMed ID: 26402096
[TBL] [Abstract][Full Text] [Related]
17. Expression of the hyperphosphorylated tau attenuates ER stress-induced apoptosis with upregulation of unfolded protein response.
Liu XA; Song J; Jiang Q; Wang Q; Tian Q; Wang JZ
Apoptosis; 2012 Oct; 17(10):1039-49. PubMed ID: 22802092
[TBL] [Abstract][Full Text] [Related]
18. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer's disease.
Huang HC; Tang D; Lu SY; Jiang ZF
Neurol Res; 2015 Apr; 37(4):366-74. PubMed ID: 25310352
[TBL] [Abstract][Full Text] [Related]
20. Autophagic degradation of tau in primary neurons and its enhancement by trehalose.
Krüger U; Wang Y; Kumar S; Mandelkow EM
Neurobiol Aging; 2012 Oct; 33(10):2291-305. PubMed ID: 22169203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
